Literature DB >> 27234695

Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.

Negar Abbasi Aval1, Jalil Pirayesh Islamian2, Milad Hatamian3, Mohammad Arabfirouzjaei4, Jafar Javadpour5, Mohammad-Reza Rashidi6.   

Abstract

In the present study, a series of multifunctional drug delivery systems based on mesostructured hydroxyapatite coating and superparamagnetic nanoparticles with pH-responsive characters was prepared. The structure of each new synthesized nanoscale composite was fully characterized by XRD, FTIR, TEM, VSM and BET. The results showed a good ordered mesostructure having large pores, high pore volume, high surface area, and varied super paramagnetic properties. The mesoporous hydroxyapatite coated super paramagnetic Fe3O4 nanoparticles were applied as a drug delivery carrier loaded with doxorubicin (DOX) as a model drug. The storage/release properties of the developed nonocarriers in phosphate buffer saline (PBS) were studied in two certain pHs: pH=7.4 (the human blood pH) and pH=5.5 (pH of cancer cells). The large pores in the synthesized mesoporous acted as an excellent carrier for DOX molecules with a loading efficiency of ≈93% which is much higher than that of the conventional hydroxyapatite particles. When the pH of the release medium (PBS) was changed from 7.4 to 5.5, the drug release increased significantly from 10% of the adsorbed drug to about 70%. DOX-loaded mesostructure hydroxyapatite reduced the viability of SKBR3 and T47D cells by 54.7 and 57.3%, respectively, which were very similar to 56.8 and 60.4% reduction resulted from free DOX incubation. This new drug delivery system which benefits from both super paramagnetic properties and pH-responsive performances may serve as a suitable platform for developing new biocompatible drug carriers and could have a good potential use in targeted cancer therapy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer treatment; Doxorubicin; Drug delivery system; Mesoporous hydroxyapatite; Superparamagnetic iron oxide nanoparticles

Mesh:

Substances:

Year:  2016        PMID: 27234695     DOI: 10.1016/j.ijpharm.2016.05.046

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Biodegradable Carbonate Apatite Nanoparticle as a Delivery System to Promote Afatinib Delivery for Non-Small Cell Lung Cancer Treatment.

Authors:  Nian N N Maarof; Emilia Abdulmalek; Sharida Fakurazi; Mohd Basyaruddin Abdul Rahman
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

2.  Mesoporous Iron(III)-Doped Hydroxyapatite Nanopowders Obtained via Iron Oxalate.

Authors:  Margarita A Goldberg; Marat R Gafurov; Fadis F Murzakhanov; Alexander S Fomin; Olga S Antonova; Dinara R Khairutdinova; Andrew V Pyataev; Olga N Makshakova; Anatoliy A Konovalov; Alexander V Leonov; Suraya A Akhmedova; Irina K Sviridova; Natalia S Sergeeva; Sergey M Barinov; Vladimir S Komlev
Journal:  Nanomaterials (Basel)       Date:  2021-03-22       Impact factor: 5.076

Review 3.  Magnetic hydroxyapatite: a promising multifunctional platform for nanomedicine application.

Authors:  Sudip Mondal; Panchanathan Manivasagan; Subramaniyan Bharathiraja; Madhappan Santha Moorthy; Hye Hyun Kim; Hansu Seo; Kang Dae Lee; Junghwan Oh
Journal:  Int J Nanomedicine       Date:  2017-11-22

4.  Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.

Authors:  Jieqiong Zhan; Zhiqiang Ma; Dan Wang; Xinfang Li; Xiangui Li; Lijing Le; Anfeng Kang; Pengwei Hu; Lan She; Feng Yang
Journal:  Int J Nanomedicine       Date:  2017-04-10

Review 5.  Approaches on Ferrofluid Synthesis and Applications: Current Status and Future Perspectives.

Authors:  Oscar Oehlsen; Sussy I Cervantes-Ramírez; Pabel Cervantes-Avilés; Illya A Medina-Velo
Journal:  ACS Omega       Date:  2022-01-21

Review 6.  Hydroxyapatite Nanoparticles for Improved Cancer Theranostics.

Authors:  Saeid Kargozar; Sahar Mollazadeh; Farzad Kermani; Thomas J Webster; Simin Nazarnezhad; Sepideh Hamzehlou; Francesco Baino
Journal:  J Funct Biomater       Date:  2022-07-20

Review 7.  Hydroxyapatite Biobased Materials for Treatment and Diagnosis of Cancer.

Authors:  María Del Carmen De Lama-Odría; Luis J Del Valle; Jordi Puiggalí
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 8.  Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity.

Authors:  Laís Salomão Arias; Juliano Pelim Pessan; Ana Paula Miranda Vieira; Taynara Maria Toito de Lima; Alberto Carlos Botazzo Delbem; Douglas Roberto Monteiro
Journal:  Antibiotics (Basel)       Date:  2018-06-09

9.  In Vivo and In Vitro Anticancer Activity of Doxorubicin-loaded DNA-AuNP Nanocarrier for the Ovarian Cancer Treatment.

Authors:  Chang-Seuk Lee; Tae Wan Kim; Da Eun Oh; Su Ok Bae; Jaesung Ryu; Hyejeong Kong; Hyeji Jeon; Hee Kyung Seo; Seob Jeon; Tae Hyun Kim
Journal:  Cancers (Basel)       Date:  2020-03-09       Impact factor: 6.639

10.  One-pot hydrothermal synthesis of a magnetic hydroxyapatite nanocomposite for MR imaging and pH-Sensitive drug delivery applications.

Authors:  Mehraneh Kermanian; Mehran Naghibi; Somayeh Sadighian
Journal:  Heliyon       Date:  2020-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.